Malignant Peripheral Nerve Sheath Tumor - 15 Studies Found Recruiting : Multi-Institutional Registry for Malignant Peripheral Nerve Sheath Tumors : Malignant Peripheral Nerve Sheath Tumors : 2017-04-13 Terminated : Imatinib Mesylate Treatment of Patients With Malignant Peripheral Nerve Sheath Tumors : Malignant Peripheral Nerve Sheath Tumors : 2007-01-25 : Drug: imatinib mesylate Recruiting : A Study of Pembrolizumab in Patients With Malignant Peripheral Nerve Sheath Tumor (MPNST), Not Eligible for Curative Surgery : Malignant Peripheral Nerve Sheath Tumour (MPNST) : 2016-02-04 : Drug: Pembrolizumab Other Name: Keytruda Recruiting : PLX3397 Plus Sirolimus in Unresectable Sarcoma and Malignant Peripheral Nerve Sheath Tumors : Sarcoma Malignant Peripheral Nerve Sheath Tumors : 2015-10-21 : Drug: PLX3397 PLX3397 is a sel Active, not recruiting : SARC023: Ganetespib and Sirolimos in Patients With MPNST (Malignant Peripheral Nerve Sheath Tumors) : Malignant Peripheral Nerve Sheath Tumors (MPNST) Sarcoma < : 2013-11-25 : Drug: ganetespib 200 mg/m² Recruiting : Vaccine Therapy in Treating Patients With Malignant Peripheral Nerve Sheath Tumor That is Recurrent or Cannot Be Removed by Surgery : Metastatic Malignant Peripheral Nerve Sheath Tumor Neurofibroma : 2016-02-25 : Procedure: Computed Tomography Active, not recruiting : SARC016: Study of Everolimus With Bevacizumab to Treat Refractory Malignant Peripheral Nerve Sheath Tumors : Malignant Peripheral Nerve Sheath Tumors MPNST Drug: everolimus 10 mg tablet Active, not recruiting : Lorvotuzumab Mertansine in Treating Younger Patients With Relapsed or Refractory Wilms Tumor, Rhabdomyosarcoma, Neuroblastoma, Pleuropulmonary Blastoma, Malignant Peripheral Nerve Sheath Tumor, or Synovial Sarcoma : Pleuropulmonary Blastoma Recurrent Malignant Peripheral Nerve Sheath T : 2015-05-20 : Other: Laboratory Biomarker Analysis Completed : S0330 Erlotinib in Treating Patients With Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumor : Sarcoma : 2003-09-10 : Drug: erlotinib hydrochloride 150 mg per day, daily until disease progression Completed : Combination Chemotherapy in Treating Patients With Stage III or Stage IV Malignant Peripheral Nerve Sheath Tumors : Neurofibromatosis Type 1 Sarcoma : 2006-03-15 : Biological: filgrastim Given s Next >>>
